Herceptin reduced HER2-positive gene-associated breast cancer recurrences 52 percent.
Avastin proved effective against breast cancer.
Low-grade ductal carcinoma in situ becomes invasive cancer in 40 percent of patients over 40 years.
Combined chemotherapy and hormone therapy cut death in half within 15 years from recurring breast cancer.
Consuming 33.3 fat grams daily reduces breast cancer recurrence 30% over five years.
Exercise increases breast cancer survival 50%.
Low melatonin levels in night-time workers increased breast cancer.
Benign "proliferative" lesions correlate with later breast cancer.
At 65 and older, early smaller localized tumors accounted for 96% of survival improvement; 38% under 50.
